Loading...
Loading...
Found 105 Skills
Transform GWAS signals into actionable drug targets and repurposing opportunities. Performs locus-to-gene mapping, target druggability assessment, existing drug identification, safety profile evaluation, and clinical trial matching. Use when discovering drug targets from GWAS data, finding drug repurposing opportunities from genetic associations, or translating GWAS findings into therapeutic leads.
Map environmental/industrial chemicals to mechanistic adverse outcome pathways (AOPs) using AOPWiki, quantify toxicological hazard (PubChemTox GHS/carcinogen classification, LD50 values), and link chemical stressors to gene targets and disease endpoints via CTD for regulatory risk assessment. Use when asked about AOP stressor mapping, GHS hazard categories, LD50 data, IARC carcinogen classification, or mechanism-based risk assessment for non-drug chemicals.
Find and retrieve proteomics datasets from public repositories including MassIVE and ProteomeXchange (which aggregates PRIDE, PeptideAtlas, jPOST, and iProX). Search by species, keyword, or accession. Get detailed dataset metadata including instruments, publications, species, modifications, and file counts. Use when asked to find proteomics datasets, search for mass spectrometry data, look up ProteomeXchange or MassIVE accessions, or discover publicly available proteomics experiments for a given organism or topic.
Analyze microbiome and metagenomics data using MGnify, GTDB, ENA, and literature tools. Search studies by biome/keyword, retrieve taxonomic profiles and functional annotations, classify genomes with GTDB taxonomy, and find related publications. Use for human gut microbiome, soil/ocean metagenomics, and environmental microbiology research.
TCGA/GDC cancer genomics analysis -- cohort construction, clinical metadata retrieval, somatic mutation profiling, copy number variation analysis, survival analysis, and clinical variant interpretation. Use when users ask about TCGA data, GDC cancer cohorts, somatic mutation frequencies, Kaplan-Meier survival, CNV profiles in cancer, or OncoKB interpretation of cancer variants.
Comprehensive ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) profiling for drug candidates. Integrates ADMET-AI predictions, SwissADME drug-likeness, PubChemTox experimental toxicity, ChEMBL clinical data, Lipinski rule-of-five, and CYP interaction data. Use for drug-likeness assessment, BBB penetration, bioavailability, hepatotoxicity prediction, ADME/PK profiling, or screening compound libraries before lab testing.
Design novel protein therapeutics (binders, enzymes, scaffolds) using AI-guided de novo design. Uses RFdiffusion for backbone generation, ProteinMPNN for sequence design, ESMFold/AlphaFold2 for validation. Use when asked to design protein binders, therapeutic proteins, or engineer protein function.
Discover novel small molecule binders for protein targets using structure-based and ligand-based approaches. Creates actionable reports with candidate compounds, ADMET profiles, and synthesis feasibility. Use when users ask to find small molecules for a target, identify novel binders, perform virtual screening, or need hit-to-lead compound identification.
Analyze metabolomics data including metabolite identification, quantification, pathway analysis, and metabolic flux. Processes LC-MS, GC-MS, NMR data from targeted and untargeted experiments. Performs normalization, statistical analysis, pathway enrichment, metabolite-enzyme integration, and biomarker discovery. Use when analyzing metabolomics datasets, identifying differential metabolites, studying metabolic pathways, integrating with transcriptomics/proteomics, discovering metabolic biomarkers, performing flux balance analysis, or characterizing metabolic phenotypes in disease, drug response, or physiological conditions.
Production-ready microscopy image analysis and quantitative imaging data skill for colony morphometry, cell counting, fluorescence quantification, and statistical analysis of imaging-derived measurements. Processes ImageJ/CellProfiler output (area, circularity, intensity, cell counts), performs Dunnett's test, Cohen's d effect size, power analysis, Shapiro-Wilk normality tests, two-way ANOVA, polynomial regression, natural spline regression with confidence intervals, and comparative morphometry. Supports CSV/TSV measurement tables, multi-channel fluorescence data, colony swarming assays, and neuron counting datasets. Use when analyzing microscopy measurement data, colony area/circularity, cell count statistics, swarming assays, co-culture ratio optimization, or answering questions about imaging-derived quantitative data.
Predict patient response to immune checkpoint inhibitors (ICIs) using multi-biomarker integration. Given a cancer type, somatic mutations, and optional biomarkers (TMB, PD-L1, MSI status), performs systematic analysis across 11 phases covering TMB classification, neoantigen burden estimation, MSI/MMR assessment, PD-L1 evaluation, immune microenvironment profiling, mutation-based resistance/sensitivity prediction, clinical evidence retrieval, and multi-biomarker score integration. Generates a quantitative ICI Response Score (0-100), response likelihood tier, specific ICI drug recommendations with evidence, resistance risk factors, and a monitoring plan. Use when oncologists ask about immunotherapy eligibility, checkpoint inhibitor selection, or biomarker-guided ICI treatment decisions.
Search and analyze cryo-EM maps, single particle structures, tomography datasets, and raw micrograph data from EMDB, EMPIAR, and CryoET Data Portal. Cross-reference with PDB structures and AlphaFold predictions. Use for cryo-EM map discovery, structure fitting analysis, raw data access, and tomography exploration.